Life expectancy of patients with neovascular glaucoma drained by Molteno implants

Clinical and Experimental Ophthalmology

Volumn 32, Issue 4, 2004, Pages 360-363

  Blanc, John Paul ^a   Molteno, Anthony C B ^b   Fuller, J Robert ^b   Bevin, Tui H ^b   Herbison, Peter ^b  

^a DUNEDIN HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Molteno implant; Mortality; Neovascular glaucoma

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLAUCOMA DRAINAGE IMPLANT; HUMAN; INTRAOCULAR PRESSURE; LIFE EXPECTANCY; LIFESPAN; MAJOR CLINICAL STUDY; MALE; NEOVASCULAR GLAUCOMA; POPULATION RESEARCH; RETINA VEIN OCCLUSION; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL DRAINAGE; SURVIVAL RATE; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GLAUCOMA, NEOVASCULAR; HUMANS; INTRAOCULAR PRESSURE; LIFE EXPECTANCY; MALE; MIDDLE AGED; MOLTENO IMPLANTS; NEW ZEALAND; SURVIVAL RATE; VISUAL ACUITY;

EID: 4444332645     PISSN: 14426404     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2004.00837.x     Document Type: Article

References (18)

1. Duke-Elder S, Jay B. Glaucoma and hypotony. In: Duke-Elder S, ed, Syslem of Ophthalmology, Vol, XI. Disease of the lens and vitreous; glaucoma and hypotony. London: Henry Kimpton, 1969; 667-83.
2. Molteno ACB, Van Rooyen MMB, Bartholomew RS. Implants for draining neovascular glaucoma. Br J Ophthalmol 1977; 61: 120-25.
3. Molteno ACB, Haddad PJ. The visual outcome in cases of neovascular glaucoma. Aust NZ J Ophthalmol 1985; 13: 329-35.
4. Molteno ACB. Low tension neovascular glaucoma treated by draining implant. Trans Ophthalmol Soc NZ 1983; 35: 81-4.
5. Krupin T, Kaufman P, Mandell AI et al. Long-term results of valve implants in filtering surgery for eyes with neovascular glaucoma. Am J Ophthalmol 1983; 95: 775-82.
6. Mermoud A, Salmon JF, Alexander P, Straker C, Murray ADN. Molteno tube implantation for neovascular glaucoma. Long-term results and factors influencing the outcome. Ophthalmology 1993; 100: 897-902.
7. Statistics New Zealand. New Zealand Life Tables 1995-1997. Wellington: Statistics New Zealand, 1998.
8. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 38: 933-42.
9. Finnish Cancer Registry. SURV2: Software for Relative Survival Analysis, Version 2.02h. Helsinki: Finnish Cancer Registry, 1998. Available from: http://www.cancerregistry.fi/surv2
10. Klein R, Moss SE, Klein BEK, DeMets DL. Relation of ocular and systemic factors to survival in diabetes. Arch Intern Med 1989; 149: 266-72.
11. Podgor MJ, Cassel GH, Kannel WB. Lens changes and survival in a population-based study. N Eng J Med 1985; 313: 1438-44.
12. Klein R, Klein BEK, Scot F, Moss MA. Age-related eye disease and survival. The Beaver Dam Eye Study. Arch Ophthalmol 1995; 113: 333-9.
13. Helbig H, Kellner U, Bornfeld N, Foerster MH. Life expectancy of diabetic patients undergoing vitreous surgery. Br J Ophthalmol 1996; 80: 640-3.
14. Egge K, Zahl PH. Survival of glaucoma patients. Acta Ophthalmol 1999; 77: 397-401.
15. Hiller R, Podgor MJ, Sperduto RD, Wilson PWF, Chew EY, D'Agostino RB. High intraocular pressure and survival: The Framingham Studies. Am J Ophthalmol 1999; 128: 440-5.
16. McCarty CA, Nanjan MB, Taylor HR. Vision impairment predicts 5-year mortality. Br J Ophthalmol 2001; 85: 322-6.
17. Rogot E, Goldberg ID, Goldstein H. Survivorship and cause of death among the blind. J Chron Dis 1966; 19: 179-97.
18. Ministry of Health. Progress on Health Outcome Targets, 1999. Wellington: Ministry of Health, 1999; 167-71.